BACKGROUND AND PURPOSE: White matter injury (WMI) is the leading cause of brain injury in preterm survivors and results in myelination failure. Although axonal degeneration occurs in necrotic lesions, the role of axonopathy in myelination failure remains controversial for diffuse non-necrotic WMI, which is currently the major form of WMI. We determined the burden of axonopathy in diffuse lesions. METHODS: We analyzed WMI in a preterm fetal sheep model of global cerebral ischemia that replicates the relative burden of necrotic and non-necrotic human WMI. WMI was analyzed at 1 or 2 weeks after ischemia and identified by ex vivo high-field (11.7 Tesla) magnetic resonance imaging of fixed brain tissue. Axonal integrity was analyzed by immunohistochemical detection of axon injury markers and by transmission electron microscopy to quantify axon loss and degeneration in magnetic resonance imaging-defined lesions. RESULTS: Axonal degeneration, defined by staining for neurofilament protein and β-amyloid precursor protein, was restricted to discrete necrotic foci with robust microglial activation. Unexpectedly, axonal degeneration was not visualized in the major form of WMI, which comprised large non-necrotic lesions with diffuse reactive astrogliosis. In these major lesions, quantitative electron microscopy studies confirmed no significant differences in the density of intact and degenerating axons or in the distribution of axon diameters relative to controls. CONCLUSIONS: The mechanism of myelination failure differs significantly in perinatal WMI dependent on the burden of necrosis. Axonopathy is associated with focal necrotic injury but not with primary diffuse non-necrotic lesions, which supports that intact axons in the primary lesions are potential targets for myelination.
BACKGROUND AND PURPOSE:White matter injury (WMI) is the leading cause of brain injury in preterm survivors and results in myelination failure. Although axonal degeneration occurs in necrotic lesions, the role of axonopathy in myelination failure remains controversial for diffuse non-necrotic WMI, which is currently the major form of WMI. We determined the burden of axonopathy in diffuse lesions. METHODS: We analyzed WMI in a preterm fetal sheep model of global cerebral ischemia that replicates the relative burden of necrotic and non-necrotichuman WMI. WMI was analyzed at 1 or 2 weeks after ischemia and identified by ex vivo high-field (11.7 Tesla) magnetic resonance imaging of fixed brain tissue. Axonal integrity was analyzed by immunohistochemical detection of axon injury markers and by transmission electron microscopy to quantify axon loss and degeneration in magnetic resonance imaging-defined lesions. RESULTS:Axonal degeneration, defined by staining for neurofilament protein and β-amyloid precursor protein, was restricted to discrete necrotic foci with robust microglial activation. Unexpectedly, axonal degeneration was not visualized in the major form of WMI, which comprised large non-necrotic lesions with diffuse reactive astrogliosis. In these major lesions, quantitative electron microscopy studies confirmed no significant differences in the density of intact and degenerating axons or in the distribution of axon diameters relative to controls. CONCLUSIONS: The mechanism of myelination failure differs significantly in perinatal WMI dependent on the burden of necrosis. Axonopathy is associated with focal necrotic injury but not with primary diffuse non-necrotic lesions, which supports that intact axons in the primary lesions are potential targets for myelination.
Authors: A Hirayama; Y Okoshi; Y Hachiya; Y Ozawa; M Ito; Y Kida; Y Imai; S Kohsaka; S Takashima Journal: Clin Neuropathol Date: 2001 Mar-Apr Impact factor: 1.368
Authors: Stephen A Back; Byung Hee Han; Ning Ling Luo; Charlene A Chricton; Steve Xanthoudakis; John Tam; Kara L Arvin; David M Holtzman Journal: J Neurosci Date: 2002-01-15 Impact factor: 6.167
Authors: Stephane V Sizonenko; Ernest Sirimanne; Yvette Mayall; Peter D Gluckman; Terrie Inder; Chris Williams Journal: Pediatr Res Date: 2003-05-07 Impact factor: 3.756
Authors: Joshua R Buser; Jennifer Maire; Art Riddle; Xi Gong; Thuan Nguyen; Kerst Nelson; Ning Ling Luo; Jennifer Ren; Jaime Struve; Larry S Sherman; Steven P Miller; Vann Chau; Glenda Hendson; Praveen Ballabh; Marjorie R Grafe; Stephen A Back Journal: Ann Neurol Date: 2012-01 Impact factor: 10.422
Authors: James J P Alix; Christian Zammit; Art Riddle; Charles K Meshul; Stephen A Back; Mario Valentino; Robert Fern Journal: Ann Neurol Date: 2012-12 Impact factor: 10.422
Authors: Alexander Drobyshevsky; Rugang Jiang; Laixiang Lin; Matthew Derrick; Kehuan Luo; Stephen A Back; Sidhartha Tan Journal: Ann Neurol Date: 2014-03-13 Impact factor: 10.422
Authors: Justin M Dean; Evelyn McClendon; A Roger Hohimer; Christopher D Kroenke; Kelly Hansen; Aryan Azimi-Zonooz; Kevin Chen; Art Riddle; Xi Gong; Elica Sharifnia; Matthew Hagen; Tahir Ahmad; Lindsey A Leigland; Stephen A Back Journal: Sci Transl Med Date: 2013-01-16 Impact factor: 17.956